Incyte
Hervé Lamarque is a seasoned professional with extensive experience in access, pricing, health economics, and business development within the pharmaceutical industry. Currently serving as Division VP and Head of Access, Pricing, HEOR, and BD for Incyte in Europe since October 2017, Hervé has successfully spearheaded access strategies that enhanced market entry and pricing outcomes for innovative therapies. Prior roles at prominent organizations such as Bristol-Myers Squibb, sanofi-aventis, and Amgen International include leadership in pricing and reimbursement strategies, contributing to successful product launches and securing first-to-market positions. Hervé also contributes to academia as an instructor and session leader for a Master’s course at EPFL, focusing on drug and MedTech product development. Educational qualifications include an EMBA from INSEAD and a background in Biology from the University of Montpellier.
This person is not in any offices
Incyte
22 followers
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.